It’s about sticking to the basics, growing — and much more. One of Greenberg Traurig’s top corporate lawyers shares his insights about leading a medical device company to an acquisition or IPO.

As co-chair Greenberg Traurig’s Global Life Sciences and Medical Technology Group and Co-Chair of the firm’s Atlanta Corporate and Securities Group, Wayne Elowe focuses on corporate counseling, cross-border and complex commercial transactions. He is especially involved in mergers and acquisitions, joint ventures, strategic investments, licensing and development deals, and other collaborative transactions, working with client located in the U.S., Asia and Europe.

Leading a young medtech company to a successful exit, according to Elowe, is all about sticking to the basics: identifying a target market, regulatory, intellectual property, not burning through funding too quickly, and more. Entrepreneurs need to keep their company’s momentum going, attack and resolve their problems in the marketplace, and create a well-defined story.

“When you get into the exit stage, your story should be well- defined. You should know what you’re presenting to the buyers,” Elowe recently told our sister site Medical Design & Outsourcing.

Go to MDO and discover insights from Elowe about the present state of medtech M&A and IPOs, as well as advice on how young medical device companies can make the most of the present environment.